Cenix BioScience - About the company
Cenix BioScience is a funded company based in Dresden (Germany), founded in 1999 by Christophe Echeverri. It operates as a Limited information available. The company has 373 active competitors, including 41 funded and 54 that have exited. Its top competitors include companies like Novartis, Catalent and Surrozen.
Key Metrics
Founded Year
1999
Location
Dresden, Germany
Stage
Funding Raised
Investors
Ranked
197th among 373 active competitors
Employee Count
2 as on Jul 31, 2026
Sign up to download Cenix BioScience's company profile
Cenix BioScience's funding and investors
Cenix BioScience is a funded company. Cenix BioScience has 2 institutional investors.
View details of Cenix BioScience's funding rounds and investors
Cenix BioScience's founders and board of directors
Founder? Claim ProfileThe founders of Cenix BioScience is Christophe Echeverri.
Here are the details of Cenix BioScience's key team members:
- Christophe Echeverri: Founder of Cenix BioScience.
View details of Cenix BioScience's Founder profiles and Board Members
Cenix BioScience's employee count trend
Cenix BioScience has 2 employees as of Jul 26. Here is Cenix BioScience's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cenix BioScience's Competitors and alternates
Top competitors of Cenix BioScience include Novartis, Catalent and Surrozen. Here is the list of Top 10 competitors of Cenix BioScience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
2nd | Catalent 2007, Somerset (United States), Acquired | Provider of development, manufacturing, and packaging solutions for medicines and supplements | - | 68/100 | |
3rd | Surrozen 2016, San Francisco (United States), Public | Pioneering targeted regenerative antibodies to repair tissue and restore organ function | $133M | 59/100 | |
4th | Biofortuna 2008, Birkenhead (United Kingdom), Series A | Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services | $21.6M | 55/100 | |
5th | Acclinate 2020, Birmingham (United States), Series A | Provider of clinical trial services to biopharma sector | $15.5M | 55/100 | |
6th | Curia 1991, Albany (United States), Acquired | Provider of drug research & development, testing, and consulting services | - | 53/100 | |
7th | Sunflower Therapeutics 2018, Hingham (United States), Series A | Provider of drug development & research services for multiple therapeutic areas | $5.64M | 52/100 | |
8th | WuXi Biologics 2008, Shanghai (China), Public | Developer and manufacturer for protein therapeutics | - | 52/100 | |
9th | BioFactura 2004, Frederick (United States), Series B | Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs | $7.8M | 51/100 | |
10th | ![]() Ventus Therapeutics 2019, Boston (United States), Series C | Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment | $300M | 51/100 | |
197th | Cenix BioScience 1999, Dresden (Germany), Funding Raised | Limited information available | - | 20/100 |
Looking for more details on Cenix BioScience's competitors? Click here to see the top ones
Cenix BioScience's Investments and acquisitions
Cenix BioScience has made no investments or acquisitions yet.
Reports related to Cenix BioScience
Here is the latest report on Cenix BioScience's sector:
Are you a Founder ?
FAQs about Cenix BioScience
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
